Johnson & Johnson vaccine could hit vaccination sites by Tuesday
The first doses of COVID-19 vaccine from Johnson & Johnson could reach vaccination sites as early as Tuesday, White House officials said on Sunday.
About 3.9 million cans have been shipped and another 16 million will be shipped by the end of March. After Johnson & Johnson's single-dose vaccine received emergency approval on Saturday, the U.S. now has three vaccine options that all can safely and effectively prevent serious illness, hospitalizations and deaths, a senior administrator told USA Today .
In the US clinical trial, the Johnson & Johnson vaccine had a 72 percent effectiveness rate and was nearly 100 percent effective in preventing hospitalizations and death. "The availability of different types of vaccines, particularly vaccines with different dosage recommendations, storage and handling requirements, can give the public, jurisdictions and vaccine providers more options and flexibility," said Rochelle Walensky, director of the Centers for Disease Control and Prevention a statement. "If you get the first vaccine available, you are protecting us all from COVID-19."
More stories from theweek.com
5 heavenly funny cartoons about Perseverance's Martian adventures
Chloé Zhao is the first Asian woman to win the Golden Globe for best director
The forgotten nuclear threat
Mention your own website in this post for Advertisement
Electrical problem strikes Iran's Natanz nuclear facility
Official: Chinese vaccines' effectiveness low
Las Vegas family awarded $29.5M in allergic reaction case
What Kind of Perfume You Should Wear, Based on Your Zodiac Sign
How lockdowns, quarantines and COVID-19 testing will change summer travel in 2021
Prince Philip didn't want a big funeral, but things will look very different when Queen Elizabeth II dies